Preimplantation Genetic Testing Market Strategy Guide: Unlocking Success in a High-Growth Sector

Preimplantation Genetic Testing Market Size The global Preimplantation Genetic Testing (PGT) market was valued at USD 848.11 million in 2024 and is projected to grow from USD 905.87 million in 2025 to USD 1534.47 million by 2033 , exhibiting a CAGR of 6.81% during the forecast period. PGT has become integral to Assisted Reproductive Technologies (ART), offering early detection of genetic abnormalities in embryos before implantation. The growth is primarily driven by rising infertility rates, increasing awareness of hereditary diseases, technological advancements in genetic screening (NGS, PCR), and the growing trend of delayed parenthood. Market Opportunities Expansion in Emerging Markets Emerging economies such as India, China, Brazil, and the Middle East present untapped growth opportunities. Rising infertility rates, enhanced healthcare infrastructure, and government initiatives like India's National Health Mission have fueled demand for ART and PGT. Investments in AI-dri...